New molecular targets in rheumatoid arthritis: focus on TAK1 signaling and neutrophils
New molecular targets in rheumatoid arthritis: focus on TAK1 signaling and neutrophils
批准号:
405240
负责人:
McDonald Patrick P
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-03-01 至 2020-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Rheumatoid arthritis (RA) is one of the most prevalent chronic inflammatory disorders in North America; it currently affects about 300,000 Canadians, and costs our economy a staggering 5.8 billion per year in direct and indirect costs. RA is characterized
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New molecular targets in rheumatoid arthritis: Focus on TAK1 signaling and neutrophils
-
批准号:442963
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2020
-
负责人:McDonald Patrick P
-
依托单位:
Neutrophil 2018
-
批准号:372765
-
项目类别:Miscellaneous Programs
-
资助金额:$0.73万
-
财政年份:2017
-
负责人:McDonald Patrick P
-
依托单位:
Neutrophil 2014
-
批准号:298905
-
项目类别:Miscellaneous Programs
-
资助金额:$1.71万
-
财政年份:2013
-
负责人:McDonald Patrick P
-
依托单位:
New molecular targets in gouty arthritis
-
批准号:238282
-
项目类别:Operating Grants
-
资助金额:$50.05万
-
财政年份:2011
-
负责人:McDonald Patrick P
-
依托单位:
海外基金